How has been the historical performance of Dr Reddy's Labs?

Answer:The historical performance of Dr Reddy's Labs shows a consistent growth trajectory in net sales and profitability over the years.

Breakdown:
Dr Reddy's Labs has demonstrated significant growth in net sales, increasing from 15,448.20 Cr in Mar'19 to 32,643.90 Cr in Mar'25. This upward trend is reflected in total operating income, which also rose from 15,448.20 Cr in Mar'19 to 32,643.90 Cr in Mar'25. The company's operating profit (PBDIT) has similarly improved, reaching 9,644.40 Cr in Mar'25, up from 3,515.70 Cr in Mar'19. Profit before tax has shown a remarkable increase from 2,292.00 Cr in Mar'19 to 7,657.80 Cr in Mar'25, while profit after tax has grown from 1,906.20 Cr to 5,703.50 Cr over the same period. The company's total assets have expanded significantly, from 22,005.40 Cr in Mar'20 to 47,594.10 Cr in Mar'25, indicating robust asset growth. Total liabilities have also increased, from 22,005.40 Cr in Mar'20 to 47,594.10 Cr in Mar'25, reflecting the company's expansion strategy. Cash flow from operating activities has remained positive, with a notable cash flow of 4,642.00 Cr in Mar'25, contributing to a closing cash balance of 1,459.00 Cr. Overall, Dr Reddy's Labs has shown strong financial performance with increasing revenues, profits, and asset growth over the years.